ONEVIEW HEALTHCARE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.31 AUD | -3.12% |
|
-1.59% | +29.17% |
| Apr. 23 | Oneview Healthcare Posts 9% Rise in Net Operating Cashflow in March Quarter | MT |
| Apr. 02 | Oneview Healthcare Inks Master Services Agreement with Inova Health for 1,900 Beds | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 37.27 | 98.8 | 127.6 | - | - |
| Enterprise Value (EV) 1 | 37.27 | 87.25 | 121.1 | 125 | 124.5 |
| P/E ratio | -3.5 x | -7.4 x | -21 x | -46.1 x | 62.9 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 10.5 x | 5.67 x | 5.03 x | 3.84 x |
| EV / Revenue | - | 9.28 x | 5.38 x | 4.93 x | 3.75 x |
| EV / EBITDA | - | -11.1 x | -24.2 x | -58.2 x | 53.7 x |
| EV / FCF | - | -11.8 x | -23.7 x | -32 x | 249 x |
| FCF Yield | - | -8.46% | -4.21% | -3.12% | 0.4% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 532,405 | 667,323 | 673,782 | - | - |
| Reference price 2 | 0.0700 | 0.1481 | 0.1894 | 0.1894 | 0.1894 |
| Announcement Date | 2/23/23 | 2/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 9.397 | 22.52 | 25.37 | 33.2 |
| EBITDA 1 | - | -7.887 | -5.004 | -2.146 | 2.316 |
| EBIT 1 | - | -8.373 | -5.4 | -2.4 | 1.8 |
| Operating Margin | - | -89.1% | -23.98% | -9.46% | 5.42% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income 1 | -10.87 | -8.935 | -5.376 | -2.518 | 1.866 |
| Net margin | - | -95.08% | -23.87% | -9.92% | 5.62% |
| EPS 2 | -0.0200 | -0.0200 | -0.009000 | -0.004110 | 0.003010 |
| Free Cash Flow 1 | - | -7.382 | -5.1 | -3.9 | 0.5 |
| FCF margin | - | -78.56% | -22.65% | -15.37% | 1.51% |
| FCF Conversion (EBITDA) | - | - | - | - | 21.58% |
| FCF Conversion (Net income) | - | - | - | - | 26.8% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 2/23/23 | 2/27/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 3.014 | 4.356 | 5.041 | 8.6 | 6.1 | 7.8 | - |
| EBITDA 1 | - | - | -3.915 | -1.9 | -3.1 | -1.2 | -0.8 |
| EBIT 1 | - | - | -4.049 | -2.2 | -3.3 | -1.4 | -1.1 |
| Operating Margin | - | - | -80.33% | -25.58% | -54.1% | -17.95% | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income 1 | - | -4.462 | -4.473 | -2.2 | -3.3 | -1.4 | -1.1 |
| Net margin | - | -102.42% | -88.73% | -25.58% | -54.1% | -17.95% | - |
| EPS 2 | -0.0300 | - | -0.0100 | -0.004000 | -0.006000 | -0.002000 | -0.002000 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 8/31/20 | 8/28/23 | 2/27/24 | - | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 11.5 | 6.5 | 2.6 | 3.1 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -7.38 | -5.1 | -3.9 | 0.5 |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | 0.12 | 0.2 | 0.2 | 0.2 |
| Capex / Sales | - | 1.26% | 0.89% | 0.79% | 0.6% |
| Announcement Date | 2/23/23 | 2/27/24 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.1894
EUR
Average target price
0.28
EUR
Spread / Average Target
+47.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.17% | 136M | |
| +11.17% | 322B | |
| +24.75% | 216B | |
| +2.41% | 149B | |
| +10.65% | 56.27B | |
| +8.71% | 32.13B | |
| -4.57% | 27.45B | |
| +103.03% | 22.62B | |
| +20.22% | 19.55B | |
| +13.06% | 14.69B |
- Stock Market
- Equities
- ONE Stock
- Financials Oneview Healthcare PLC
